Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?

By McCluskey A.   Keane M.A.   Mudgee L.-M.   Sim A.T.R.   Sakoff J.   Quinn R.J.  

European Journal of Medicinal Chemistry, Vol. 35, Iss. 10, 2000-10 ,pp. : 957-964

Elsevier

Access to resources Recommend Favorite

Recent discovery and development of protein tyrosine phosphatase inhibitors

By Kim Hwa-Ok   Blaskovich Mark A  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 871-905

Informa Healthcare

Access to resources Recommend Favorite

Ligand based Drug Design of New Heterocyclic Imines of GABA Analogues: A Molecular Docking Approach for the Discovery of New GABA-AT Inhibitors

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 17, Iss. 1, 2017-02 ,pp. : 58-63

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors

By Sawyer Tomi K  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 1-19

Informa Healthcare

Access to resources Recommend Favorite

Discovery of Novel CYP17 Inhibitors for the Treatment of Prostate Cancer with Structure-Based Drug Design

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 5, 2009-07 ,pp. : 337-344

Bentham Science Publishers

Access to resources Recommend Favorite